Unexpected decrease in in vivo binding of [3H]QNB in the mouse cerebral cortex in the developing brain - A comparison with [11C]NMPB.

[1]  Geor Bakker,et al.  123I-Iododexetimide Preferentially Binds to the Muscarinic Receptor Subtype M1 In Vivo , 2015, The Journal of Nuclear Medicine.

[2]  B. Lipworth.  Emerging role of long acting muscarinic antagonists for asthma , 2014, British journal of clinical pharmacology.

[3]  B. Olshansky,et al.  Cardiac effects of muscarinic receptor antagonists used for voiding dysfunction. , 2011, British journal of clinical pharmacology.

[4]  U. Hegerl,et al.  Cholinergic receptor subtypes and their role in cognition, emotion, and vigilance control: An overview of preclinical and clinical findings , 2011, Psychopharmacology.

[5]  F. Bergquist,et al.  Motor activity-induced dopamine release in the substantia nigra is regulated by muscarinic receptors , 2010, Experimental Neurology.

[6]  O. Inoue,et al.  Comparative Measurement of In Vivo and In Vitro Receptor Binding in the Same Rat Brain , 2006 .

[7]  A. E. Power.  Muscarinic cholinergic contribution to memory consolidation: with attention to involvement of the basolateral amygdala. , 2004, Current medicinal chemistry.

[8]  M. Yamada,et al.  Regional brain uptake of the muscarinic ligand, [18F]FP-TZTP, is greatly decreased in M2 receptor knockout mice but not in M1, M3 and M4 receptor knockout mice , 2003, Neuropharmacology.

[9]  A. Gee,et al.  Changes in apparent rates of receptor binding in the intact brain in relation to the heterogeneity of reaction environments. , 1999, Critical reviews in neurobiology.

[10]  O. Inoue,et al.  Evaluation of in vivo binding properties of 3H-NMPB and 3H-QNB in mouse brain , 1999, Journal of Neural Transmission.

[11]  R. Reba,et al.  Autoradiographic Evidence That QNB Displays in Vivo Selectivity for the m2 Subtype , 1995, NeuroImage.

[12]  B. Zeeberg,et al.  [3H]QNB displays in vivo selectivity for the m2 subtype. , 1994, Life sciences.

[13]  S. Ali,et al.  Iron/ascorbate-induced lipid peroxidation changes membrane fluidity and muscarinic cholinergic receptor binding in rat frontal cortex , 1993, Neurochemistry International.

[14]  R. Giménez,et al.  Changes in brain striatum dopamine and acetylcholine receptors induced by chronic CDP‐choline treatment of aging mice , 1991, British journal of pharmacology.

[15]  N. Birdsall,et al.  Muscarinic receptor subtypes. , 1990, Annual review of pharmacology and toxicology.

[16]  W. Hung,et al.  Differential distribution of muscarinic receptor subtypes and their regulation by G-protein in rat brain. , 1990, General pharmacology.

[17]  T. Haga,et al.  Effect of the lipid environment on the differential affinity of purified cerebral and atrial muscarinic acetylcholine receptors for pirenzepine. , 1989, Molecular pharmacology.

[18]  D. Greenblatt,et al.  Dietary choline intake modulates benzodiazepine receptor binding and gamma-aminobutyric acidA receptor function in mouse brain. , 1989, The Journal of pharmacology and experimental therapeutics.

[19]  K. Gulya,et al.  [3H]AF-DX 116 labels subsets of muscarinic cholinergic receptors in rat brain and heart. , 1987, Life sciences.

[20]  D. Mash,et al.  Autoradiographic localization of M1 and M2 muscarine receptors in the rat brain , 1986, Neuroscience.

[21]  I. Okun,et al.  Inactivation of muscarinic acetylcholine receptors in brain synaptic membranes by free fatty acids. Evaluation of the role of lipid phase. , 1986, General physiology and biophysics.

[22]  O. Inoue,et al.  Computer-controlled large scale production of high specific activity [11C]RO 15-1788 for PET studies of benzodiazepine receptors. , 1985, The International journal of applied radiation and isotopes.

[23]  C S Patlak,et al.  Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data , 1983, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[24]  W. Sadee,et al.  [3H]diprenorphine receptor binding in vivo and in vitro. , 1982, European journal of pharmacology.

[25]  M. Shinitzky,et al.  Lipid fluidity markedly modulates the binding of serotonin to mouse brain membranes. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[26]  K. Mullis,et al.  Opiate antagonist receptor binding in vivo: evidence for a new receptor binding model , 1980, Brain Research.

[27]  W. Hoss,et al.  Analysis of regional variations in the affinities of muscarinic agonists in the rat brain , 1980, Brain Research.

[28]  Y. Kloog,et al.  Characterization of muscarinic acetylcholine receptors from mouse brain: evidence for regional heterogeneity and isomerization. , 1979, Molecular pharmacology.

[29]  M. Hanley,et al.  [3H]‐QUINUCLIDINYL BENZILATE BINDING TO MUSCARINIC RECEPTORS IN RAT BRAIN: COMPARISON OF RESULTS FROM INTACT BRAIN SLICES AND HOMOGENATES , 1979, British journal of pharmacology.

[30]  R. Aronstam,et al.  Development of muscarinic cholinergic receptors in inbred strains of mice: Identification of receptor heterogeneity and relation to audiogenic seizure susceptibility , 1979, Brain Research.

[31]  Y. Kloog,et al.  Regional heterogeneity of muscarinic receptors of mouse brain , 1979, FEBS letters.

[32]  M. Palkovits,et al.  Regional distribution of muscarinic cholinergic receptors in rat brain , 1978, Brain Research.

[33]  Y. Kloog,et al.  Studies on muscarinic acetylcholine receptors from mouse brain: Characterization of the interaction with antagonists , 1978, Brain Research.

[34]  S. H. Snyder,et al.  In vivo identification of muscarinic cholinergic receptor binding in rat brain. , 1974, Brain research.

[35]  S. Snyder,et al.  Muscarinic cholinergic binding in rat brain. , 1974, Proceedings of the National Academy of Sciences of the United States of America.